CN1884501A - Glutamine synthetase and its dedicated expression engineered bacteria and uses - Google Patents
Glutamine synthetase and its dedicated expression engineered bacteria and uses Download PDFInfo
- Publication number
- CN1884501A CN1884501A CNA2006100894847A CN200610089484A CN1884501A CN 1884501 A CN1884501 A CN 1884501A CN A2006100894847 A CNA2006100894847 A CN A2006100894847A CN 200610089484 A CN200610089484 A CN 200610089484A CN 1884501 A CN1884501 A CN 1884501A
- Authority
- CN
- China
- Prior art keywords
- glutamine
- glutamine synthetase
- engineering bacteria
- bacteria
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020002326 glutamine synthetase Proteins 0.000 title claims abstract description 50
- 241000894006 Bacteria Species 0.000 title claims abstract description 48
- 102000005396 glutamine synthetase Human genes 0.000 title claims abstract description 42
- 230000014509 gene expression Effects 0.000 title claims abstract description 22
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims abstract description 41
- 241000186226 Corynebacterium glutamicum Species 0.000 claims abstract description 13
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000005215 recombination Methods 0.000 claims abstract description 5
- 230000006798 recombination Effects 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 24
- 238000000855 fermentation Methods 0.000 claims description 18
- 230000004151 fermentation Effects 0.000 claims description 18
- 241000588724 Escherichia coli Species 0.000 claims description 15
- 150000003863 ammonium salts Chemical class 0.000 claims description 12
- 239000013604 expression vector Substances 0.000 claims description 10
- 238000003259 recombinant expression Methods 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 230000008521 reorganization Effects 0.000 claims description 7
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 5
- 229940073490 sodium glutamate Drugs 0.000 claims description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical group [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 4
- 230000000968 intestinal effect Effects 0.000 claims description 4
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 claims description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 2
- 239000005695 Ammonium acetate Substances 0.000 claims description 2
- 229940024606 amino acid Drugs 0.000 claims description 2
- 150000001413 amino acids Chemical group 0.000 claims description 2
- 229940043376 ammonium acetate Drugs 0.000 claims description 2
- 235000019257 ammonium acetate Nutrition 0.000 claims description 2
- 235000019270 ammonium chloride Nutrition 0.000 claims description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 2
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 2
- 230000008676 import Effects 0.000 claims description 2
- 230000006698 induction Effects 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract description 15
- 238000004519 manufacturing process Methods 0.000 abstract description 15
- 230000008859 change Effects 0.000 abstract description 11
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract description 5
- 230000004048 modification Effects 0.000 abstract description 5
- 238000012986 modification Methods 0.000 abstract description 5
- 239000002126 C01EB10 - Adenosine Substances 0.000 abstract description 3
- 229960005305 adenosine Drugs 0.000 abstract description 3
- 230000010933 acylation Effects 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 238000010961 commercial manufacture process Methods 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 description 42
- 108090000790 Enzymes Proteins 0.000 description 42
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 37
- 230000006154 adenylylation Effects 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 7
- 229960002989 glutamic acid Drugs 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 230000003321 amplification Effects 0.000 description 6
- 238000006555 catalytic reaction Methods 0.000 description 6
- 238000003199 nucleic acid amplification method Methods 0.000 description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 108010039224 Amidophosphoribosyltransferase Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000003471 mutagenic agent Substances 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 102100039239 Amidophosphoribosyltransferase Human genes 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010327 methods by industry Methods 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a glutamine synthetase and its special-purpose expression project bacterium and its allocation, which is to provide a glutamine synthetase and its special-purpose expression project bacterium and its allocation. The said glutamine synthetase is prepared by abrupt change of the 405th amino acid residue of amino end to phenylalanine corynebacterium glutamicum. The engineering bacteria prepare the recombination bacteria by importing the recombination expression carrier containing the said glutamine synthetase gene into host bacteria. The glutamine synthetase produced by the engineering bacteria can specially act on NH4+ and aminoglutaric acid, the durability to the high concentration ammonium ion has been distinctively improved because of the dissolution of adenosine acylation modification, the major bottleneck of glutamine with enzymatical production has been solved, and the concentration of the obtained glutamine can reach 47.6g/L. The invention has higher practicability and flackery and has wide application foreground in glutamine commercial manufacture.
Description
Technical field
The present invention relates to glutamine synthetase and dedicated expression engineered bacteria thereof and application, particularly relate to the application in producing glutamine of a kind of glutamine synthetase and dedicated expression engineered bacteria thereof and this project bacterium.
Background technology
Glutamine is a kind of important foodstuff additive and medicine material, has higher nutritive value and pharmaceutical use.The market requirement of glutamine is growing, at present, the glutamine market value is about ten thousand yuans of 10-15 per ton, the demand of domestic glutamine is about 5000 tons/year, market value is above 500,000,000 yuan, if can create bigger economic benefit after being processed into medicament or healthcare products, market outlook are wide.The major country of production of glutamine is Japan, Korea S and China in the world, and the fermentation concentration of Japan is up to 60g/L, and Korea S has also reached 50g/L.At present, in the domestic optimization that mainly rests on selection by mutation and zymotechnique in the research aspect the glutamine ferment.Though obtained the production bacterial strain of some glutamine by selection by mutation, final fermentation concentration and productive rate be low than Japan and Korea S all, thereby be difficult to provide support for the scale operation of glutamine.
The Production by Enzymes glutamine has great application prospect, its basic ideas be with monosodium glutamate and ammonium salt as raw material, glutamine synthetase (glutamine synthetase, GS) and the synthetic glutamine of catalysis under the condition of energy ATP is provided.Compare with microbe fermentation method, the Production by Enzymes glutamine has advantages such as cost is low, reactions steps is simple, side reaction is few, easily separated.At present, the existing report that successfully synthesizes glutamine on a small quantity with enzyme process, Yang Chunyu etc. utilize Corynebacterium glutamicum (C.glutamicum) fermentation to obtain the GS enzyme, through obtaining containing the crude enzyme liquid of GS enzyme after the cytoclasis, join again and contain L-glutamic acid, in the phosphate buffered saline buffer of ammonium salt and ATP, the transformation efficiency of L-glutamic acid has reached 94.8% (Yang Chunyu after testing, Ma Cuiqing, permitted equality. the enzymatic conversion method glutamine. the process engineering journal, 2002,2 (6): 529 ~ 533), but this method adopts the mode that adds ATP that energy is provided, ATP costs an arm and a leg, thereby can't be used for suitability for industrialized production; Chen Qunying etc. utilize engineered method, realized the high expression level of GS enzyme in intestinal bacteria, after extracting the GS enzyme of expressing in the reorganization mycetocyte it is joined in the fermentation system of fresh yeast saccharomyces cerevisiae, utilize the ATP that glycolysis glucose produces in the yeast fermentation process to be GS enzyme catalysis L-glutamic acid and NH
4 +Synthetic glutamine provides energy, in the method, the GS enzyme of escherichia coli expression accounts for 80% of total mycoprotein, and utilize yeast fermentation to produce the energy derive problem that ATP has solved GS enzyme catalysis process well, but the fermentative preparation of GS enzyme and enzyme catalysis process are finished in two living things systems, need carry out ultrasonic broken wall to recombination bacillus coli and extract the GS enzyme, in addition, for make ATP and ADP can be between yeast cell and catalyst system cyclic regeneration, also to change its permeability with the O for toluene yeast cells wall, thereby complicated operation, the suitability for industrialized production difficulty big (Chen Qunying, Chen Guoan, Xue Bin etc. the research of the efficient synthetic L-glutaminate of genetically engineered enzyme process combining yeast energy coupling connection. the biotechnology journal, 2004,20 (3): 456-460).Above-mentioned result of study shows that adopting yeast fermentation to produce ATP and enzyme process produces glutamine the heavy industrialization application difficulty of coupling connection is bigger mutually.
The Production by Enzymes glutamine is to use NH
4 +Make raw material with L-glutamic acid, through glutamine synthetase catalytic production glutamine.There are two kinds of forms in the GS enzyme in bacterial body: a kind of is unmodified, and another kind is through the adenosine covalent modification.To be exactly AMP combine the process that produces GS (AMP) with covalent and the tyrosine residues on the peptide chain to the adenylylation of GS enzyme, the adenylylation of GS enzyme and go adenylylation all by adenylyl transferase (adenylyltransferase, ATase) catalysis.Adenylylation can make the activity of GS enzyme reduce or forfeiture.In addition, the adenylylation of GS enzyme modification inactivation and inverse process thereof also are subjected to the regulation and control of ammonium salt concentration, grow into the intracellular GS enzyme of stationary phase and do not modified by adenosine under the culture condition of restriction ammonium salt; Under the culture condition of excessive ammonium salt, the adenylylation degree strengthens, and the GS enzyme activity descends even inactivation.But in the process of Production by Enzymes glutamine, ammonium salt is the catalytic substrate of GS enzyme, and desire improves glutamine output, must strengthen the supply of ammonium salt, to realize the conversion to glutamine of L-glutamic acid and ammonium salt.Therefore, press for the method for a kind of releasing, to keep the activity of GS enzyme in the catalytic production glutamine process to the modification of GS enzyme adenylylation.
Summary of the invention
The purpose of this invention is to provide a kind of glutamine synthetase of removing the adenylylation modification.
Glutamine synthetase provided by the present invention is the glutamine synthetase that sports the Corynebacterium glutamicum (C.glutamicum) of phenylalanine from aminoterminal the 405th amino acids residue.
The gene of above-mentioned glutamine synthetase of encoding also belongs to protection scope of the present invention.
The 3rd purpose of the present invention provides a kind of dedicated expression engineered bacteria of glutamine synthetase.
The dedicated expression engineered bacteria of glutamine synthetase provided by the present invention is that the recombinant expression vector that will contain described glutamine synthetase gene imports the reorganization bacterium that obtains in the host bacterium.
The carrier that sets out that is used to make up described recombinant expression vector can be at expression in escherichia coli expression of exogenous gene carrier, as pET-3a, pET-30a, pET-28a, pET-28b or pET-28c etc.
Be the carrier that sets out with pET-3a, the recombinant expression vector that contains described glutamine synthetase gene of structure is pET-3a/GSIM.
Described host can be intestinal bacteria, excellent bacillus, yeast or Bacillus subtilus etc., is preferably intestinal bacteria.
Colibacillary concrete bacterial strain is not had particular requirement, and selection is that non-constant width is general, all can such as E.coli BL21 (DE3), E.coli BL21 (DE3) plys, BLR (DE3) or B834 etc.
With E.coli BL21 (DE3) is starting strain, and pET-3a/GSIM is imported reorganization bacterium called after BL21 (DE3) GSIM that E.coli BL21 (DE3) obtains.
Above-mentioned recombinant expression vector and reorganization bacterium all can make up according to ordinary method.
Another object of the present invention provides a kind of preparation method of glutamine.
The preparation method of glutamine provided by the present invention, be the dedicated expression engineered bacteria of the above-mentioned glutamine synthetase of fermentation, obtain glutamine synthetase, add substrate ammonium salt and Sodium Glutamate again, continue fermentation 24-48 hour down at 20-37 ℃, obtain glutamine; NH in the described fermented liquid
4 +Concentration be 10-100g/L, the concentration of Sodium Glutamate is 10-150g/L.
Can adopt the conventional culture condition that makes up the used starting strain of engineering bacteria that engineering bacteria is cultivated, when described engineering bacteria is recombination bacillus coli, need to add the IPTG inductor, add IPTG concentration be 0.01-1.2mmol/L, inducing temperature is 20-39 ℃, and induction time is 2-8 hour.
The selection of described ammonium salt is diversified, as ammonium chloride, ammonium sulfate, ammonium nitrate or ammonium acetate etc.; Leavening temperature behind the adding substrate is preferably 30 ℃.
The invention provides a kind of glutamine synthetase.This enzyme is on the basis of the glutamine synthetase of original Corynebacterium glutamicum, and the tyrosine residues in adenylylation site is sported phenylalanine.And utilize prokaryotic expression carrier will be transformed in the host bacterium encoding gene of this glutamine synthetase, obtained the expression engineering bacteria of glutamine synthetase.This project bacterium can produce enzyme higher glutamine synthetase alive after fermentation, enzyme activity can reach 1200U/L, be significantly higher than the enzyme activity of the glutamine synthetase of producing with existing bacterial strain, and this project bacterium has the expression amount height, and production cost is low, is easy to the advantage of industrialization.The glutamine synthetase that engineering bacteria of the present invention produces can change the NH that acts on of a property
4 +And L-glutamic acid, and because of having removed the adenylylation modification tolerance of high density ammonium ion is significantly improved, having solved the important bottleneck of Production by Enzymes glutamine, the concentration of the glutamine of generation is up to 47.6g/L.But the present invention has advantages of high practicability and generalization, has broad application prospects in the suitability for industrialized production of glutamine.
Below in conjunction with specific embodiment the present invention is described in further detail.
Description of drawings
Fig. 1 is the structure schema of pET-3a/GSIM
Fig. 2 is the growing state comparative result of control strain and recombinant bacterial strain in the fermenting process
Fig. 3 prepares the comparative result of glutamine for the glutamine synthetase that produces with control strain and recombinant bacterial strain fermentation
Embodiment
Method therefor is ordinary method if no special instructions among the following embodiment.The primer sequence is synthetic by match Parkson company.
The acquisition of embodiment 1, glutamine synthetase rite-directed mutagenesis gene
Adopt overlapping PCR method to the glutamine synthetase gene of Corynebacterium glutamicum (C.glutamicum) (NCBIGenBank number: Y13221) carry out rite-directed mutagenesis; the codon mutation that is about to from 5 ' end adenylylation site, 1213-1215 position tyrosine is the phenylalanine codon; and introduce the recognition site of restriction enzyme Nde I and Hind III respectively at the sequence two ends, concrete grammar may further comprise the steps:
1, first round amplification
Genomic dna with Corynebacterium glutamicum (C.glutamicum) is a template, by primer 1:5 '-ATAAGGGAGGAGTG
CATATG1) and primer 3:5 '-GGTAG (band underscore base is a restriction enzyme Nde I recognition site to GCGTTTGAAA-3 ', SEQ ID № in the sequence table:
(base is the sudden change codon to GAAGAGGTCCTTGTCCACTGGAG-3 ' in the square frame, SEQ ID № in the sequence table: 3) under the right guiding of the primer of Zu Chenging, the upstream segment of pcr amplification glutamine synthetase gene is also introduced mutating alkali yl, and the PCR reaction conditions is: 94 ℃ of sex change of elder generation 5 minutes; 94 ℃ of sex change are 30 seconds then, 58 ℃ of annealing 45 seconds, and 72 ℃ were extended totally 30 circulations 1.5 minutes; Last 72 ℃ were extended 10 minutes, took out after being cooled to 4 ℃.After reaction finishes, the PCR product is carried out 1% agarose gel electrophoresis detect, pcr amplification has gone out the single band of big or small about 1240bp as a result, conforms to expected results.
2, second take turns amplification
Genomic dna with Corynebacterium glutamicum (C.glutamicum) is a template, by primer 2: 5 '-CAAGGACCTCTTC
(base is the sudden change codon to CTACCACCAGAGGAA-3 ' in the square frame, SEQ ID № in the sequence table: 2) and primer 4:5 '-AATCAAGCTTACCACACGGAACCGTCTCACT-3 ' (band underscore base is a restriction enzyme Hind III recognition site, SEQ ID № in the sequence table: 4) under the right guiding of the primer of Zu Chenging, the downstream segment of pcr amplification glutamine synthetase gene is also introduced mutating alkali yl, and the PCR reaction conditions is: 94 ℃ of sex change of elder generation 5 minutes; 94 ℃ of sex change are 30 seconds then, 54 ℃ of annealing 45 seconds, and 72 ℃ were extended totally 30 circulations 30 seconds; Last 72 ℃ were extended 10 minutes, took out after being cooled to 4 ℃.After reaction finishes, the PCR product is carried out 1% agarose gel electrophoresis detect, pcr amplification has gone out the single band of big or small about 440bp as a result, conforms to expected results.
3, third round amplification
Upstream and downstream segment with the glutamine synthetase gene of step 1 and step 2 amplification is a template, under the right guiding of the primer of being made up of primer 1 and primer 4, carries out overlapping pcr amplification, and the PCR reaction conditions is: first 94 ℃ of sex change 5 minutes; 94 ℃ of sex change are 30 seconds then, 62 ℃ of annealing 45 seconds, and 72 ℃ were extended totally 30 circulations 1.5 minutes; Last 72 ℃ were extended 10 minutes, took out after being cooled to 4 ℃.After reaction finishes, the PCR product is carried out 1% agarose gel electrophoresis detect, pcr amplification has gone out the single band of big or small about 1660bp as a result, conforms to expected results.Reclaim and this purpose segment of purifying, it is checked order, sequencing result shows that the glutamine synthetase mutator gene of the overlapping PCR method amplification of this usefulness has SEQ ID № in the sequence table: 5 nucleotide sequence, from 5 ' end 1213-1215 bit base is the mutational site, codon mutation by tyrosine is the phenylalanine codon, and is consistent with expected results.
The structure of embodiment 2, glutamine synthetase dedicated expression engineered bacteria
One, the structure of glutamine synthetase gene expression of recombinant e. coli carrier
The glutamine synthetase mutator gene of embodiment 1 amplification is carried out after enzyme cuts with restriction enzyme Nde I and HindIII, be connected with the plasmid pET-3a (Novagen) that contains penbritin (Amp) resistance marker through the same enzyme double digestion, to connect product Transformed E .coli BL21 (DE3) competent cell, the transformant that screening has the Amp resistance, obtain containing glutamine synthetase mutator gene recombinant expression vector, called after pET-3a/GSIM, it makes up schema and sees Fig. 1.
Two, with recombinant expression vector pET-3a/GSIM transformed into escherichia coli
Recombinant expression vector pET-3a/GSIM CaCl with the step 1 structure
2Method Transformed E .coli BL21 (DE3) competent cell is coated transformant on the LB resistant panel that contains 100 μ g/mL Amp, cultivates 12-16h down at 37 ℃.After growing single bacterium colony, picking list bacterium colony is as template, carrying out bacterium colony PCR under the guiding of primer 1 and primer 4 identifies, can obtain the segmental positive clone of 1660bp through pcr amplification, the upgrading grain, carrying out single endonuclease digestion with restriction enzyme Nde I and Hind III respectively earlier identifies, cut the segmental positive plasmid of acquisition 5780bp through Nde I enzyme, cut the segmental positive plasmid of acquisition 5780bp through Hind III enzyme, carrying out double digestion with Nde I and Hind III again identifies, cut acquisition 4120bp and the segmental positive plasmid of 1660bp through enzyme, qualification result shows and has obtained the positive recombinant that correct conversion has goal gene, can be used as the engineering bacteria of expressing glutamine synthetase, with this project bacterium called after BL21 (DE3) GSIM.
The preparation of embodiment 2, glutamine
Reorganization bacterium BL21 (DE3) GSIM that embodiment 1 is made up is inoculated in the 50mL LB liquid nutrient medium, be contrast with E.coli BL21 (DE3), 2-3 hour OD to bacterium liquid of cultivation in 37 ℃, 170rpm shaking table
600Value is 0.6-1.0, the basic identical (see figure 2) of the growing state of control strain and recombinant bacterial strain, add the IPTG that final concentration is 0.1mmol/L then, continue cultivation and made the GS expression of enzymes in 23 hours, GS enzyme work in the recombinant bacterial strain can reach 122.84U/L after testing, comparison has improved 6 times according to bacterium E.coli BL21 (DE3), adds substrate NH then
4Cl (10-100g/L fermented liquid) and Sodium Glutamate (10-150g/L fermented liquid) are adjusted shaking table temperature to 30 ℃, continue fermentation 24-48h, make the GS enzyme catalysis L-glutamic acid and the synthetic glutamine of ammonium of fermentation expression.After the fermentation ends; detect the glutamine concentration in the fermented liquid; the concentration that the result produces the glutamine of GS enzyme preparation with the fermentation of reorganization bacterium is up to 47.6g/L; be 51.8 times of (see figure 3)s that contrast bacterium E.coliBL21 (DE3) produces glutamine concentration; show that glutamine synthetase adenylylation site mutation has significantly improved the ability of glutamine synthetase tolerance high density ammonium ion; solved the important bottleneck of Production by Enzymes glutamine, engineering strain of the present invention can be the large-scale industrial production glutamine and provides support.
Sequence table
<160>5
<210>1
<211>30
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>1
ataagggagg?agtgcatatg?gcgtttgaaa 30
<210>2
<211>31
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>2
caaggacctc?ttcgaactac?caccagagga?a 31
<210>3
<211>31
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>3
ggtagttcga?agaggtcctt?gtccactgga?g 31
<210>4
<211>31
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>4
aatcaagctt?accacacgga?accgtctcac?t 31
<210>5
<211>1434
<212>DNA
<213〉artificial sequence
<220>
<223>
<400>5
atggcgtttg?aaaccccgga?agaaattgtc?aagttcatca?aggatgaaaa?cgtcgagttc 60
gttgacgttc?gattcaccga?ccttcccggc?accgagcagc?acttcagcat?cccagctgcc 120
agcttcgatg?cagatacaat?cgaagaaggt?ctcgcattcg?acggatcctc?gatccgtggc 180
ttcaccacga?tcgacgaatc?tgacatgaat?ctcctgccag?acctcggaac?ggccaccctt 240
gatccattcc?gcaaggcaaa?gaccctgaac?gttaagttct?tcgttcacga?tcctttcacc 300
cgcgaggcat?tctcccgcga?cccacgcaac?gtggcacgca?aggcagagca?gtacctggca 360
tccaccggca?ttgcagacac?ctgcaacttc?ggcgccgagg?ctgagttcta?cctcttcgac 420
tccgttcgct?actccaccga?gatgaactcc?ggcttctacg?aagtagatac?cgaagaaggc 480
tggtggaacc?gtggcaagga?aaccaacctc?gacggcaccc?caaacctggg?cgcaaagaac 540
cgcgtcaagg?gtggctactt?cccagtagca?ccatacgacc?aaaccgttga?cgtgcgcgat 600
gacatggttc?gcaacctcgc?agcttccggc?ttcgctcttg?agcgtttcca?ccacgaagtc 660
ggtggcggac?agcaggaaat?caactaccgc?ttcaacacca?tgctccacgc?ggcagatgat 720
atccagacct?tcaagtacat?catcaagaac?accgctcgcc?tccacggcaa?ggctgcaacc 780
ttcatgccta?agccactggc?tggcgacaac?ggttccggca?tgcacgctca?ccagtccctc 840
tggaaggacg?gcaagccact?cttccacgat?gagtccggct?acgcaggcct?gtccgacatc 900
gcccgctact?acatcggcgg?catcctgcac?cacgcaggcg?ctgttctggc?gttcaccaac 960
gcaaccctga?actcctacca?ccgtctggtt?ccaggcttcg?aggctccaat?caacctggtg 1020
tactcacagc?gcaaccgttc?cgctgctgtc?cgtatcccaa?tcaccggatc?caacccgaag 1080
gcaaagcgca?tcgaattccg?cgctccagac?ccatcaggca?acccatacct?gggctttgca 1140
gcgatgatga?tggccggcct?cgacggcatc?aagaaccgca?tcgagccaca?cgctccagtg 1200
gacaaggacc?tcttcgaact?accaccagag?gaagctgcat?ccattccaca?ggcaccaacc 1260
tccctggaag?catccctgaa?ggcactgcag?gaagacaccg?acttcctcac?cgagtctgac 1320
gtcttcaccg?aggatctcat?cgaggcgtac?atccagtaca?agtacgacaa?cgagatctcc 1380
ccagttcgcc?tgcgcccaac?cccgcaggaa?ttcgaattgt?acttcgactg?ctaa 1434
Claims (9)
1, glutamine synthetase is the glutamine synthetase that sports the Corynebacterium glutamicum of phenylalanine from aminoterminal the 405th amino acids residue.
2, the gene of the described glutamine synthetase of coding claim 1.
3, expressing the engineering bacteria of glutamine synthetase, is that the recombinant expression vector that will contain the described glutamine synthetase gene of claim 2 imports the reorganization bacterium that obtains in the host bacterium.
4, engineering bacteria according to claim 3 is characterized in that: the carrier that sets out that is used to make up described recombinant expression vector is a coli expression carrier.
5, engineering bacteria according to claim 4 is characterized in that: described recombinant expression vector is pET-3a/GSIM.
6, according to claim 3 or 4 or 5 described engineering bacterias, it is characterized in that: described host is intestinal bacteria.
7, a kind of preparation method of glutamine, be the engineering bacteria of the described expression glutamine synthetase of fermentation claim 3, obtain glutamine synthetase, add substrate ammonium salt and Sodium Glutamate again, continue fermentation 24-48 hour down at 20-37 ℃, obtain glutamine; NH in the described fermented liquid
4 +Concentration be 10-100g/L, the concentration of Sodium Glutamate is 10-150g/L.
8, method according to claim 7 is characterized in that: when described engineering bacteria is recombination bacillus coli, add the IPTG inductor, add IPTG concentration be 0.01-1.2mmol/L, inducing temperature is 20-39 ℃, induction time is 2-8 hour.
9, according to claim 7 or 8 described methods, it is characterized in that: described ammonium salt is ammonium chloride, ammonium sulfate, ammonium nitrate or ammonium acetate; Leavening temperature behind the adding substrate is 30 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100894847A CN100392075C (en) | 2006-06-29 | 2006-06-29 | Glutamine synthetase and its dedicated expression engineered bacteria and uses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100894847A CN100392075C (en) | 2006-06-29 | 2006-06-29 | Glutamine synthetase and its dedicated expression engineered bacteria and uses |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1884501A true CN1884501A (en) | 2006-12-27 |
CN100392075C CN100392075C (en) | 2008-06-04 |
Family
ID=37582807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100894847A Expired - Fee Related CN100392075C (en) | 2006-06-29 | 2006-06-29 | Glutamine synthetase and its dedicated expression engineered bacteria and uses |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100392075C (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107603938A (en) * | 2017-10-30 | 2018-01-19 | 天津科技大学 | It is overexpressed the genetic engineering bacterium and its construction method of heterologous glutamyl amine synzyme |
CN110373369A (en) * | 2019-06-25 | 2019-10-25 | 华中农业大学 | A kind of recombined bacillus subtilis engineering bacteria, construction method and its application producing pig glutamine synthelase |
CN110951661A (en) * | 2019-12-26 | 2020-04-03 | 新疆梅花氨基酸有限责任公司 | Corynebacterium glutamicum capable of producing L-glutamine at high yield and construction method and application thereof |
CN111117940A (en) * | 2019-12-04 | 2020-05-08 | 天津大学 | Escherichia coli engineering bacterium and method for high yield of pentamethylene diamine |
CN114375332A (en) * | 2020-03-04 | 2022-04-19 | Cj第一制糖株式会社 | Modified polypeptide of glutamine synthetase and method for producing L-glutamine using same |
WO2023180398A1 (en) | 2022-03-23 | 2023-09-28 | Boehringer Ingelheim International Gmbh | Bacterial glutamine synthetase as selection marker in mammalian cells |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2230114C2 (en) * | 2001-11-30 | 2004-06-10 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" | Mutant glutamine synthetase, dna fragment, strain of escherichia coli as p roducer of l-glutamine and method for preparing l-amino acids |
-
2006
- 2006-06-29 CN CNB2006100894847A patent/CN100392075C/en not_active Expired - Fee Related
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107603938A (en) * | 2017-10-30 | 2018-01-19 | 天津科技大学 | It is overexpressed the genetic engineering bacterium and its construction method of heterologous glutamyl amine synzyme |
CN107603938B (en) * | 2017-10-30 | 2018-10-12 | 天津科技大学 | It is overexpressed the genetic engineering bacterium and its construction method of heterologous glutamyl amine synzyme |
CN110373369A (en) * | 2019-06-25 | 2019-10-25 | 华中农业大学 | A kind of recombined bacillus subtilis engineering bacteria, construction method and its application producing pig glutamine synthelase |
CN111117940A (en) * | 2019-12-04 | 2020-05-08 | 天津大学 | Escherichia coli engineering bacterium and method for high yield of pentamethylene diamine |
CN111117940B (en) * | 2019-12-04 | 2022-06-28 | 天津大学 | Escherichia coli engineering bacterium and method for high yield of pentamethylene diamine |
CN110951661A (en) * | 2019-12-26 | 2020-04-03 | 新疆梅花氨基酸有限责任公司 | Corynebacterium glutamicum capable of producing L-glutamine at high yield and construction method and application thereof |
CN110951661B (en) * | 2019-12-26 | 2024-05-31 | 新疆梅花氨基酸有限责任公司 | Corynebacterium glutamicum with high L-glutamine yield, construction method and application thereof |
CN114375332A (en) * | 2020-03-04 | 2022-04-19 | Cj第一制糖株式会社 | Modified polypeptide of glutamine synthetase and method for producing L-glutamine using same |
JP2022529297A (en) * | 2020-03-04 | 2022-06-20 | シージェイ チェイルジェダン コーポレーション | Glutamine synthetase mutant polypeptide and L-glutamine production method using it |
JP7371119B2 (en) | 2020-03-04 | 2023-10-30 | シージェイ チェイルジェダン コーポレーション | Glutamine synthetase mutant polypeptide and L-glutamine production method using the same |
CN114375332B (en) * | 2020-03-04 | 2024-01-12 | Cj第一制糖株式会社 | Modified polypeptide of glutamine synthetase and method for producing L-glutamine using the same |
WO2023180398A1 (en) | 2022-03-23 | 2023-09-28 | Boehringer Ingelheim International Gmbh | Bacterial glutamine synthetase as selection marker in mammalian cells |
Also Published As
Publication number | Publication date |
---|---|
CN100392075C (en) | 2008-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108424900B (en) | Nitrilase mutant and construction method and application thereof | |
CN111607623B (en) | Method for preparing alpha-ketoisovalerate by transforming escherichia coli through metabolic engineering | |
CN103146720B (en) | Trans-4-hydroxy-L-proline hydroxylase modifying gene with high transformation rate and application thereof | |
CN1884501A (en) | Glutamine synthetase and its dedicated expression engineered bacteria and uses | |
CN104928226A (en) | Recombined corynebacterium glutamicum and application of corynebacterium glutamicum to 5-aminolevulinic acid production | |
CN107794275B (en) | Recombinant pichia pastoris for producing (+) gamma-lactamase and construction method and application thereof | |
CN107201374B (en) | Construction method and application of optical pure meso-2, 3-butanediol high-yield engineering strain | |
CN113073074B (en) | Genetically engineered bacterium for efficiently synthesizing riboflavin and application thereof | |
CN102604899B (en) | Genetic engineering bacterium containing L-alanine racemase gene and application thereof | |
CN1693466A (en) | Engineering bacteria for producing 5-amino acetyl propionic acid and its constructing method | |
CN108546697A (en) | Enzyme process prepares beta alanine | |
CN107201375B (en) | Construction method and application of genetic engineering strain for producing (R, R) -2, 3-butanediol | |
CN1908159A (en) | D-amino acid preparation strain and construction method thereof | |
CN112725322B (en) | Aspartase mutant, coding gene and engineering bacterium | |
CN1302112C (en) | Production for phytase with high living rate high temp. resisting by pichia | |
CN115851684B (en) | Nitrilase and application thereof in methionine synthesis | |
CN1560229A (en) | Process of preparing D-amino acid oxydase | |
CN104450595B (en) | Glutamic acid decarboxylase recombinant bacterium and construction method and application thereof | |
CN107338263B (en) | Construction method for producing itaconic acid by fermenting xylose based on pichia stipitis synthetic strain | |
CN107201355B (en) | High-stereoselectivity phenylalanine deaminase mutant and application thereof | |
CN1504575A (en) | Controlling method for expression system of T7 induced by laevorotary arabinose | |
CN1869236A (en) | Production method of recombination ox intestine kinase | |
CN117946991A (en) | A-isopropyl malic acid synthase mutant and application thereof | |
CN116121141A (en) | High-yield inositol bacillus amyloliquefaciens and construction method and application thereof | |
CN115478057A (en) | Ketoreductase mutant for preparing (S) -3, 4-dihydroxy-2' -chlorophenethanol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080604 Termination date: 20100629 |